Emeren Group Announces Results of Annual General Meeting

STAMFORD, Conn., Dec. 13, 2023 /PRNewswire/ — Emeren Group Ltd ("Emeren" or…

Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent

MELBOURNE, Australia and SAN DIEGO, Dec. 13, 2023 /PRNewswire/ — Imagion Biosystems…

Quark Expeditions Invites Guests to "Raise a Glass and Stay Connected" with Free Wi-Fi and Bar Service

SEATTLE, Dec. 13, 2023 /PRNewswire/ — Quark Expeditions, the global leader in…

Bilibili Showcases Global Expansion Ambitions for Original Chinese Content at Asia TV Forum & Market

SHANGHAI, Dec. 13, 2023 /PRNewswire/ — Bilibili Inc. ("Bilibili" or the "Company"),…

Dizal's Sunvozertinib Pivotal Study Results Published in The Lancet Respiratory Medicine

SHANGHAI, Dec. 13, 2023 /PRNewswire/ — Dizal today announced that the results…

Bybit's Spot X: The Aggregator Transforming Crypto Spot Trading

DUBAI, UAE, Dec. 13, 2023 /PRNewswire/ — Bybit, the third largest crypto…

2023 South China Sea Buddhism Roundtable Held in Sri Lanka

Walking Together in Harmony and Gathering the Wisdom of the Silk Road COLOMBO, Sri…

Transcenta Announces the Publication of Preclinical Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate as Potential Novel Treatment Option for Metastatic Gastric Cancer in the European Journal of Nuclear Medicine and Molecular Imaging

PRINCETON, N.J. and SUZHOU, China, Dec. 13, 2023 /PRNewswire/ — Transcenta Holding…